Wall Street brokerages expect RTI Surgical, Inc. (NASDAQ:RTIX) to announce $69.83 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for RTI Surgical’s earnings, with estimates ranging from $69.50 million to $70.16 million. RTI Surgical reported sales of $67.62 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 3.3%. The business is scheduled to report its next earnings results on Wednesday, July 26th.
On average, analysts expect that RTI Surgical will report full-year sales of $69.83 million for the current financial year, with estimates ranging from $281.20 million to $283.06 million. For the next fiscal year, analysts expect that the firm will report sales of $294.60 million per share, with estimates ranging from $293.30 million to $295.90 million. Zacks’ sales calculations are a mean average based on a survey of sell-side research firms that cover RTI Surgical.
RTI Surgical (NASDAQ:RTIX) last posted its earnings results on Thursday, April 27th. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter. RTI Surgical had a negative net margin of 6.85% and a positive return on equity of 1.34%. The company had revenue of $69.90 million during the quarter, compared to analysts’ expectations of $67.68 million. During the same period in the previous year, the company posted $0.03 EPS. RTI Surgical’s quarterly revenue was up 3.7% compared to the same quarter last year.
Several equities analysts have weighed in on RTIX shares. Zacks Investment Research upgraded shares of RTI Surgical from a “hold” rating to a “strong-buy” rating and set a $4.25 price objective on the stock in a research report on Tuesday, February 28th. TheStreet upgraded shares of RTI Surgical from a “d+” rating to a “c-” rating in a research report on Friday, May 5th. Finally, ValuEngine upgraded shares of RTI Surgical from a “sell” rating to a “hold” rating in a research report on Friday, June 2nd.
ILLEGAL ACTIVITY NOTICE: “$69.83 Million in Sales Expected for RTI Surgical, Inc. (RTIX) This Quarter” was published by Stock Observer and is the sole property of of Stock Observer. If you are accessing this piece on another publication, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.thestockobserver.com/2017/06/20/69-83-million-in-sales-expected-for-rti-surgical-inc-rtix-this-quarter.html.
RTI Surgical (NASDAQ RTIX) remained flat at $5.40 during midday trading on Friday. 48,317 shares of the company were exchanged. The company’s market capitalization is $313.88 million. RTI Surgical has a 1-year low of $2.50 and a 1-year high of $5.45. The firm’s 50-day moving average is $4.94 and its 200 day moving average is $3.89.
In related news, EVP Kevin D. Brandt bought 33,130 shares of the firm’s stock in a transaction on Wednesday, May 3rd. The stock was bought at an average price of $4.52 per share, with a total value of $149,747.60. Following the purchase, the executive vice president now directly owns 126,215 shares of the company’s stock, valued at approximately $570,491.80. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Nicholas J. Valeriani bought 5,500 shares of the firm’s stock in a transaction on Thursday, May 4th. The shares were bought at an average cost of $4.60 per share, with a total value of $25,300.00. Following the purchase, the director now directly owns 25,770 shares in the company, valued at $118,542. The disclosure for this purchase can be found here. Insiders have acquired a total of 112,023 shares of company stock valued at $514,421 in the last three months. Company insiders own 4.90% of the company’s stock.
Several large investors have recently modified their holdings of the stock. Paradigm Capital Management Inc. NY raised its stake in shares of RTI Surgical by 3.7% in the first quarter. Paradigm Capital Management Inc. NY now owns 5,833,270 shares of the medical equipment provider’s stock worth $23,333,000 after buying an additional 208,200 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of RTI Surgical by 2.0% in the first quarter. Dimensional Fund Advisors LP now owns 3,900,031 shares of the medical equipment provider’s stock worth $15,600,000 after buying an additional 74,933 shares during the period. Vanguard Group Inc. raised its stake in shares of RTI Surgical by 0.4% in the first quarter. Vanguard Group Inc. now owns 1,930,869 shares of the medical equipment provider’s stock worth $7,724,000 after buying an additional 8,452 shares during the period. Kennedy Capital Management Inc. raised its stake in shares of RTI Surgical by 20.0% in the first quarter. Kennedy Capital Management Inc. now owns 1,422,371 shares of the medical equipment provider’s stock worth $5,689,000 after buying an additional 236,923 shares during the period. Finally, Foundry Partners LLC raised its stake in shares of RTI Surgical by 5.3% in the first quarter. Foundry Partners LLC now owns 1,039,300 shares of the medical equipment provider’s stock worth $4,157,000 after buying an additional 52,125 shares during the period. 68.74% of the stock is owned by institutional investors.
About RTI Surgical
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.